FI935065A0 - Farmaceutiska foereningar - Google Patents

Farmaceutiska foereningar

Info

Publication number
FI935065A0
FI935065A0 FI935065A FI935065A FI935065A0 FI 935065 A0 FI935065 A0 FI 935065A0 FI 935065 A FI935065 A FI 935065A FI 935065 A FI935065 A FI 935065A FI 935065 A0 FI935065 A0 FI 935065A0
Authority
FI
Finland
Prior art keywords
pharmaceutical production
pharmaceutical
production
Prior art date
Application number
FI935065A
Other languages
English (en)
Other versions
FI935065A (fi
FI103727B1 (fi
FI103727B (fi
Inventor
Colin Peter Dell
Andrew Caerwyn Williams
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929224169A external-priority patent/GB9224169D0/en
Priority claimed from GB939302367A external-priority patent/GB9302367D0/en
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of FI935065A0 publication Critical patent/FI935065A0/fi
Publication of FI935065A publication Critical patent/FI935065A/fi
Application granted granted Critical
Publication of FI103727B1 publication Critical patent/FI103727B1/fi
Publication of FI103727B publication Critical patent/FI103727B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI935065A 1992-11-18 1993-11-16 Menetelmä terapeuttisesti käyttökelpoisten 2-amino-4-substioitu-fenyyli-4H-pyrano£3,2-h|kinoliini-3-karbonitriilien valmistamiseksi FI103727B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929224169A GB9224169D0 (en) 1992-11-18 1992-11-18 Pharmaceutical compounds
GB9224169 1992-11-18
GB939302367A GB9302367D0 (en) 1993-02-06 1993-02-06 Pharmaceutical compounds
GB9302367 1993-02-06

Publications (4)

Publication Number Publication Date
FI935065A0 true FI935065A0 (fi) 1993-11-16
FI935065A FI935065A (fi) 1994-05-19
FI103727B1 FI103727B1 (fi) 1999-08-31
FI103727B FI103727B (fi) 1999-08-31

Family

ID=26301995

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935065A FI103727B (fi) 1992-11-18 1993-11-16 Menetelmä terapeuttisesti käyttökelpoisten 2-amino-4-substioitu-fenyyli-4H-pyrano£3,2-h|kinoliini-3-karbonitriilien valmistamiseksi

Country Status (16)

Country Link
US (1) US5434160A (fi)
EP (2) EP1004584A3 (fi)
JP (1) JPH06199862A (fi)
KR (1) KR940011465A (fi)
CN (1) CN1040982C (fi)
AU (1) AU668602B2 (fi)
CA (1) CA2103203A1 (fi)
CO (1) CO4130335A1 (fi)
CZ (1) CZ243493A3 (fi)
FI (1) FI103727B (fi)
HU (1) HU9303261D0 (fi)
IL (1) IL107627A (fi)
NO (1) NO304890B1 (fi)
NZ (1) NZ250195A (fi)
PL (1) PL301059A1 (fi)
TW (1) TW289755B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9306062D0 (en) * 1993-03-24 1993-05-12 Lilly Industries Ltd Pharmaceutical compounds
FR2795071B1 (fr) * 1999-06-16 2001-07-27 Adir Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2216987T3 (es) 1999-11-05 2004-11-01 Cytovia, Inc. 4h-cromeno sustituido y analogos como activadores de caspasas e industores de la apoptosis, y uso de los mismos.
EP1392683B1 (en) 2001-05-16 2009-12-02 Cytovia, Inc. Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
WO2002092076A1 (en) 2001-05-16 2002-11-21 Cytovia, Inc. Substituted coumarins and quinolines as caspases activators
US6858607B1 (en) 2001-05-16 2005-02-22 Cytovia, Inc. 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2003097806A2 (en) * 2002-05-16 2003-11-27 Cytovia, Inc. Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2003096982A2 (en) 2002-05-16 2003-11-27 Cytovia, Inc. Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
ES2403340T3 (es) 2004-09-09 2013-05-17 Howard Florey Institute Of Experimental Physiology And Medicine Inhibidores de aminopeptidasa regulada por insulina (IRAP) y usos de los mismos
US7843312B2 (en) * 2006-12-12 2010-11-30 Honeywell International Inc. Wireless control of security system with key-operated key fob
NZ585338A (en) 2007-11-19 2012-08-31 Howard Florey Inst Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof
AU2011328074B2 (en) 2010-11-12 2016-05-05 Deutsches Krebsforschungszentrum (Dkfz) Chromene derivatives and their analoga as Wnt pathway antagonists
WO2023099589A1 (en) * 2021-12-01 2023-06-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Irap inhibitors for use in the treatment of inflammatory diseases
CN115028643B (zh) * 2022-06-10 2024-03-22 中国药科大学 吡喃并喹啉衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
JPS61502124A (ja) * 1984-05-09 1986-09-25 ジ　オ−ストラリアン　ナシヨナル　ユニヴア−シテイ− 免疫応答の調節方法
JP2631710B2 (ja) * 1988-08-16 1997-07-16 日本ヘキスト・マリオン・ルセル株式会社 ピラノ〔ｆ〕キノリノン誘導体及び該化合物を有効成分とする医薬組成物
US4931221A (en) * 1988-12-30 1990-06-05 Ppg Industries, Inc. Photochromic spiropyran compounds
US5284868A (en) * 1991-10-09 1994-02-08 Eli Lilly And Company Pharmaceutical compounds
GB9306062D0 (en) * 1993-03-24 1993-05-12 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
NO934145D0 (no) 1993-11-16
CO4130335A1 (es) 1995-02-13
NO934145L (no) 1994-05-19
FI935065A (fi) 1994-05-19
EP1004584A2 (en) 2000-05-31
PL301059A1 (en) 1994-05-30
CZ243493A3 (en) 1994-06-15
IL107627A (en) 1997-04-15
EP0599514A2 (en) 1994-06-01
EP1004584A3 (en) 2000-07-05
NZ250195A (en) 1995-12-21
AU668602B2 (en) 1996-05-09
CN1092072A (zh) 1994-09-14
FI103727B1 (fi) 1999-08-31
CN1040982C (zh) 1998-12-02
IL107627A0 (en) 1994-02-27
CA2103203A1 (en) 1994-05-19
EP0599514A3 (en) 1994-07-06
JPH06199862A (ja) 1994-07-19
FI103727B (fi) 1999-08-31
US5434160A (en) 1995-07-18
HU9303261D0 (en) 1994-03-28
NO304890B1 (no) 1999-03-01
KR940011465A (ko) 1994-06-21
TW289755B (fi) 1996-11-01
AU5067193A (en) 1994-06-02

Similar Documents

Publication Publication Date Title
NO942923L (no) Medikamenter
FI930882A (fi) Farmaceutiska foereningar
DE69330973D1 (de) Vielseitig verwendbares Produktionssystem
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922958A (fi) Farmaceutisk sammansaettning
FI922252A (fi) Farmaceutisk sammansaettning
FI922316A (fi) Farmaceutisk sammansaettning
FI923581A (fi) Farmaceutisk kombinationsformation
DK229489D0 (da) Laegemiddeladsorbater
DE69301826T2 (de) Bildherstellung
NO923859D0 (no) Medikament
NO931831D0 (no) Farmasoeytiske blandinger
FI935065A (fi) Farmaceutiska foereningar
FI931251A0 (fi) Farmaceutiska foereningar
DK86492D0 (da) Laegemiddel
FI955605A0 (fi) Aryloivia lääkkeitä
FI921786A (fi) Farmaceutisk foerening
DK138592D0 (da) Tabletter
FI921785A (fi) Farmaceutisk foerening
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
FI934317A0 (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
DK137192D0 (da) Laegemiddel/-plante
TH13625EX (th) เอเซียโลไกลโคโปรตีน-ตัวยาคอนจูเกท
DK7190D0 (da) Laegemiddel
DK128993D0 (da) Laegemiddel/-plante